U.S. Markets for Critical Care Patient Management Products
U.S. Markets for Critical Care Patient Management Products
$4,750.00
This dynamic new report from Medtech Insight includes analyses of products, current/forecast markets, competitors, and opportunities in the U.S. market for critical care patient management products.
Publisher: Medtech Insight
- Description
- Contents
- Samples
Critical care in the U.S. is expanding rapidly, particularly as hospital lengths of stay decrease, and the intensity of care and acuity of patients admitted to hospitals increase. Hospitals are evolving into critical care centers to which only the most seriously ill patients are admitted. Virtually every hospital unit has a significant percentage of patients benefiting from advanced technologies and equipment necessary for sustaining life, or for rapidly identifying severe clinical conditions. Increasingly, critical care is defined not so much by a designated place in the hospital—such as the ICU—but rather by the type of assessment, monitoring, nursing care, and therapy provided.
This dynamic new report from Medtech Insight includes analyses of products, current/forecast markets, competitors, and opportunities in the U.S. market for critical care patient management products. Product areas covered by the scope of this report include drug and fluid delivery products (vascular access devices, infusion pumps, and gravity infusion systems), airway management and ventilation products (ventilators, manual resuscitators, anesthesia/respiratory masks, and supraglottic airways), and POC blood testing products (POC glucose analyzers, POC cardiac marker analyzers, POC blood gas analyzers, and POC coagulation analyzers).
During the forecast period covered by this report, the combined U.S. market for critical care patient management products is projected to increase from $3.9 billion in 2013 to $4.9 billion in the year 2018. Drug and fluid delivery products account for 59%, POC blood testing products account for 23%, and airway management/ventilation products account for the remaining 18%.
Table of Contents
U.S. Markets for Critical Care Patient Management Products Table of Contents
1. OVERVIEW OF CRITICAL CARE……………………………………………………… 1-1
1.1 Critical Care Staff …………………………………………………………………… 1-3
1.1.1 Intensivists………………………………………………………………. 1-3
1.1.2 Hospitalists……………………………………………………………… 1-4
1.1.3 Nurses……………………………………………………………………. 1-4
1.2 Critical Care Units…………………………………………………………………… 1-5
1.3 Emergency Departments…………………………………………………………. 1-5
1.4 Products and Equipment …………………………………………………………. 1-8
1.4.1 Invasive ………………………………………………………………….. 1-8
1.4.2 Noninvasive…………………………………………………………….. 1-9
1.4.3 Transport………………………………………………………………. 1-10
1.4.4 Medical Equipment Malfunctions………………………………. 1-10
1.5 Procedures Performed in the Intensive Care Unit ……………………… 1-11
1.6 Critical Access Hospital Designation ……………………………………….. 1-12
1.7 The Leapfrog Group ……………………………………………………………… 1-12
1.8 Healthcare Economics…………………………………………………………… 1-13
1.9 Demographics ……………………………………………………………………… 1-14
1.10 Managed Care……………………………………………………………………… 1-14
1.11 Mergers and Acquisitions ………………………………………………………. 1-18
1.12 Healthcare Worker Shortage ………………………………………………….. 1-18
1.12.1 Physician Shortage ………………………………………………… 1-19
1.12.2 Nursing Shortage …………………………………………………… 1-19
1.13 Group Purchasing Organizations ……………………………………………. 1-20
Exhibit 1-1: Critical Care Nursing Responsibilities………………………………………… 1-6
Exhibit 1-2: Community Hospitals in the United States, 2002-2012 ………………… 1-7
Exhibit 1-3: 2011, Personal Healthcare Service and Supply Expenditures
in the United States, by Category……………………………………………. 1-15
Exhibit 1-4: Population Forecast, by Age, 2010, 2020, and 2030………………….. 1-16
2. DRUG AND FLUID DELIVERY PRODUCTS MARKET ………………………… 2-1
2.1 Clinical Overview……………………………………………………………………. 2-1
2.2 Vascular Access Devices ………………………………………………………… 2-3
2.2.1 Central Line-Associated Blood Stream Infections …………. 2-3
2.2.2 Blood Exposure……………………………………………………….. 2-6
2.2.3 Market Analysis ……………………………………………………….. 2-6
2.2.3.1 Short Peripheral Catheters………………………….. 2-7
2.2.3.1.1 Market Forecast……………………… 2-9
2.2.3.1.2 Competitive Analysis……………….. 2-9
2.2.3.2 Midline Catheters …………………………………….. 2-11
2.2.3.2.1 Market Forecast……………………. 2-13
2.2.3.2.2 Competitive Analysis……………… 2-13
2.2.3.3 Peripherally Inserted Central Catheters ………. 2-15
2.2.3.3.1 Market Forecast……………………. 2-18
2.2.3.3.2 Competitive Analysis……………… 2-20
2.2.3.4 Central Venous Catheters …………………………. 2-20
2.2.3.4.1 Market Forecast……………………. 2-24
2.2.3.4.2 Competitive Analysis……………… 2-24
2.3 Infusion Pumps/Administration Sets………………………………………… 2-26
2.3.1 Positive Placement Needleless Connectors……………….. 2-29
2.3.2 Market Analysis ……………………………………………………… 2-30
2.3.2.1 Volumetric Infusion Pumps/
Administration Sets ………………………………….. 2-31
2.3.2.1.1 Market Forecast……………………. 2-33
2.3.2.1.2 Competitive Analysis……………… 2-36
2.3.2.2 Syringe Infusion Pumps/Administration Sets… 2-37
2.3.2.2.1 Market Forecast……………………. 2-39
2.3.2.2.2 Competitive Analysis……………… 2-39
2.3.2.3 Gravity Infusion and Elastomeric
Infusion Pump Systems…………………………….. 2-41
2.3.2.3.1 Market Forecast……………………. 2-43
2.3.2.3.2 Competitive Analysis……………… 2-45
2.4 Combined Market Analysis…………………………………………………….. 2-45
Exhibit 2-1: Central Line-Associated Blood Stream Infections,
by Healthcare Setting, 2001 and 2009 ………………………………………. 2-4
Exhibit 2-2: Vascular Access Devices, Market Forecast, by Type, 2013-2018….. 2-8
Exhibit 2-3: Short Peripheral Catheters, Market Forecast, 2013-2018 …………… 2-10
Exhibit 2-4: 2013, Short Peripheral Catheters Market, Share by Supplier………. 2-12
Exhibit 2-5: Midline Catheters, Market Forecast, 2013-2018………………………… 2-14
Exhibit 2-6: 2013, Midline Catheters Market, Share by Supplier …………………… 2-16
U.S. Markets for Critical Care Patient Management Products Table of Contents
Exhibit 2-7: Peripherally Inserted Central Catheters, Market Forecast,
2013-2018 …………………………………………………………………………… 2-19
Exhibit 2-8: 2013, Peripherally Inserted Central Catheters Market,
Share by Supplier…………………………………………………………………. 2-21
Exhibit 2-9: Central Venous Catheters, Market Forecast, 2013-2018 ……………. 2-25
Exhibit 2-10: 2013, Central Venous Catheters Market, Share by Supplier……….. 2-27
Exhibit 2-11: Infusion Pumps and Administration Sets,
Combined Market Forecast, 2013-2018 …………………………………… 2-32
Exhibit 2-12: Volumetric Infusion Pumps and Administration Sets,
Market Forecast, 2013-2018 ………………………………………………….. 2-35
Exhibit 2-13: 2013, Volumetric Infusion Pumps and Administration
Sets Market, Share by Supplier………………………………………………. 2-38
Exhibit 2-14: Syringe Infusion Pumps and Administration Sets,
Market Forecast, 2013-2018 ………………………………………………….. 2-40
Exhibit 2-15: 2013, Syringe Infusion Pumps and Administration Sets Market,
Share by Supplier…………………………………………………………………. 2-42
Exhibit 2-16: Gravity Infusion Systems, Market Forecast 2013-2018………………. 2-44
Exhibit 2-17: 2013, Gravity Infusion Systems Market, Share by Supplier…………. 2-46
Exhibit 2-18: Drug and Fluid Delivery Products, Combined Market Forecast,
2013-2018 …………………………………………………………………………… 2-48
3. AIRWAY MANAGEMENT AND VENTILATION PRODUCTS MARKET….. 3-1
3.1 Pressure Ventilators ……………………………………………………………….. 3-2
3.2 Time-Limited Ventilators………………………………………………………….. 3-4
3.3 Volume-Limited Ventilators………………………………………………………. 3-4
3.4 Breath Sequences………………………………………………………………….. 3-4
3.5 Noninvasive Ventilation …………………………………………………………… 3-5
3.6 Ventilators, Market Analysis …………………………………………………….. 3-6
3.6.1 Adult and Pediatric Ventilators …………………………………… 3-7
3.6.1.1 Market Forecast ………………………………………… 3-9
3.6.1.2 Competitive Analysis ………………………………….. 3-9
3.6.2 Neonatal Ventilators ……………………………………………….. 3-12
3.6.2.1 Market Forecast ………………………………………. 3-14
3.6.2.2 Competitive Analysis ………………………………… 3-15
3.6.3 Transport Ventilator Systems …………………………………… 3-15
3.6.3.1 Market Forecast ………………………………………. 3-18
3.6.3.2 Competitive Analysis ………………………………… 3-19
3.7 Manual Resuscitators……………………………………………………………. 3-21
3.7.1 Market Forecast …………………………………………………….. 3-24
3.7.2 Competitive Analysis ………………………………………………. 3-24
3.8 Anesthesia/Respiratory Masks ……………………………………………….. 3-26
3.8.1 Market Forecast …………………………………………………….. 3-29
3.8.2 Competitive Analysis ………………………………………………. 3-29
3.9 Supraglottic Airways ……………………………………………………………… 3-31
3.9.1 Market Forecast …………………………………………………….. 3-34
3.9.2 Competitive Analysis ………………………………………………. 3-35
3.10 Combined Market Analysis…………………………………………………….. 3-37
Exhibit 3-1: Characteristics of Mechanical Ventilators…………………………………… 3-3
Exhibit 3-2: Ventilators, Combined Market Forecast, 2013-2018 ……………………. 3-8
Exhibit 3-3: Adult and Pediatric Ventilators, Market Forecast, 2013-2018………. 3-10
Exhibit 3-4: 2013, Adult and Pediatric Ventilators Market, Share by Supplier …. 3-13
Exhibit 3-5: Neonatal Ventilators, Market Forecast, 2013-2018 ……………………. 3-16
Exhibit 3-6: 2013, Neonatal Ventilators Market, Share by Supplier……………….. 3-17
Exhibit 3-7: Transport Ventilators, Market Forecast, 2013-2018 …………………… 3-20
Exhibit 3-8: 2013, Transport Ventilators Market, Share by Supplier………………. 3-22
Exhibit 3-9: Manual Resuscitators, Market Forecast, 2013-2018 ………………….. 3-25
Exhibit 3-10: 2013, Manual Resuscitators Market, Share by Supplier……………… 3-27
Exhibit 3-11: Anesthesia/Respiratory Masks, Market Forecast, 2013-2018 ……… 3-30
Exhibit 3-12: 2013, Anesthesia/Respiratory Masks Market, Share by Supplier…. 3-32
Exhibit 3-13: Supraglottic Airways, Market Forecast, 2013-2018 ……………………. 3-36
Exhibit 3-14: 2013, Supraglottic Airways Market, Share by Supplier……………….. 3-38
Exhibit 3-15: Airway Management and Ventilation Products,
Combined Market Forecast, 2013-2018 …………………………………… 3-39
4. POINT-OF-CARE BLOOD TESTING PRODUCTS MARKET………………… 4-1
4.1 Types of Point-of-Care Instruments…………………………………………… 4-2
4.2 Quality Control……………………………………………………………………….. 4-3
4.3 Point-of-Care Blood Testing in the Critical Care Setting……………….. 4-4
4.3.1 Point-of-Care Blood Gas/Electrolyte Testing………………… 4-5
4.3.1.2 Market Forecast ………………………………………… 4-6
4.3.1.3 Competitive Analysis ………………………………….. 4-7
U.S. Markets for Critical Care Patient Management Products Table of Contents
4.3.2 Point-of-Care Cardiac Marker Testing……………………….. 4-10
4.3.2.1 Creatine Kinase-MB …………………………………. 4-12
4.3.2.2 Myoglobin……………………………………………….. 4-13
4.3.2.3 Troponin-I and Troponin-T ………………………… 4-13
4.3.2.4 B-Type Natriuretic Peptide ………………………… 4-14
4.3.2.5 Market Forecast ………………………………………. 4-15
4.3.2.6 Competitive Analysis ………………………………… 4-16
4.3.3 Point-of-Care Coagulation Testing ……………………………. 4-18
4.3.3.1 Anticoagulants…………………………………………. 4-18
4.3.3.2 Thrombosis……………………………………………… 4-20
4.3.3.3 Anticoagulation Risks and Transfusions………. 4-21
4.3.3.4 Types of Coagulation Tests……………………….. 4-22
4.3.3.5 Market Forecast ………………………………………. 4-23
4.3.3.6 Competitive Analysis ………………………………… 4-26
4.3.4 Point-of-Care Blood Glucose Testing ………………………… 4-28
4.3.4.1 Tight Glycemic Control……………………………… 4-28
4.3.4.2 Meter Accuracy ……………………………………….. 4-28
4.3.4.3 Types of Point-of-Care Blood Glucose
Testing Systems………………………………………. 4-30
4.3.4.3.1 Noninvasive Meters ………………. 4-31
4.3.4.3.2 Test Strips……………………………. 4-31
4.3.4.3.3 Lancing Devices……………………. 4-31
4.3.4.4 Market Forecast ………………………………………. 4-32
4.3.4.5 Competitive Analysis ………………………………… 4-34
4.3.5 Combined Market Analysis………………………………………. 4-35
Exhibit 4-1: Point-of-Care Blood Gas/Electrolyte Testing Products,
Market Forecast, 2013-2018 ……………………………………………………. 4-8
Exhibit 4-2: 2013, Point-of-Care Blood Gas/Electrolyte Testing
Products Market, Share by Supplier………………………………………… 4-11
Exhibit 4-3: Point-of-Care Cardiac Marker Testing Products,
Market Forecast, 2013-2018 ………………………………………………….. 4-17
Exhibit 4-4: 2013, Point-of-Care Cardiac Marker Testing
Products Market, Share by Supplier………………………………………… 4-19
Exhibit 4-5: Point-of-Care Coagulation Testing Products,
Market Forecast, 2013-2018 ………………………………………………….. 4-27
Exhibit 4-6: 2013, Point-of-Care Coagulation Testing Products Market,
Share by Supplier…………………………………………………………………. 4-29
Exhibit 4-7: Point-of-Care Blood Glucose Testing Products,
Market Forecast, 2013-2018 ………………………………………………….. 4-33
Exhibit 4-8: 2013, Point-of-Care Blood Glucose Testing Products Market,
Share by Supplier…………………………………………………………………. 4-36
Exhibit 4-9: Point-of-Care Blood Testing Products Market,
Combined Market Forecast, 2013-2018 …………………………………… 4-37
APPENDIX: COMPANY LISTING……………………………………………………………… A-1
Figure: Drug and fluid delivery products, Market share by product segment
© Pharma Intelligence UK Ltd. This document is a licensed product and is not to be reproduced or redistributed
Do you have a subscription to Datamonitor Healthcare, Biomedtracker or Meddevicetracker? You may already have access to these reports, contact your account manager or email pharma@informabi.com for further help or assistance.
U.S. Neurostimulation Devices Market, June 2015 
Sign up to the